Similar articles for PMID: 21471141

Year	Number of Results
1993	1
1995	4
1997	1
1999	3
2000	1
2001	3
2002	6
2003	3
2004	4
2005	4
2006	6
2008	5
2009	3
2010	6
2011	7
2012	10
2013	8
2014	11
2015	6
2016	6
2017	5
2018	6
2019	9
2020	9
2021	8
2022	1
2024	0

1

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia.

Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG, Koutsky LA, Sings HL, Lu S, Haupt RM, Paavonen J; FUTURE I and II Study Group. Lehtinen M, et al. Sex Transm Infect. 2011 Aug;87(5):372-6. doi: 10.1136/sti.2010.044354. Epub 2011 Apr 6. Sex Transm Infect. 2011. PMID: 21471141 Free PMC article. Clinical Trial.

2

Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.

Poljak M, Oštrbenk A, Seme K, Šterbenc A, Jančar N, Vrtačnik Bokal E. Poljak M, et al. J Clin Virol. 2016 Mar;76 Suppl 1:S29-S39. doi: 10.1016/j.jcv.2015.11.021. Epub 2015 Nov 19. J Clin Virol. 2016. PMID: 26643051

3

Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.

Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM. Zhao C, et al. Arch Pathol Lab Med. 2013 Jul;137(7):942-7. doi: 10.5858/arpa.2012-0307-OA. Epub 2012 Oct 10. Arch Pathol Lab Med. 2013. PMID: 23050808 Free article.

4

Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.

Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S. Ibáñez R, et al. BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25. BMC Infect Dis. 2012. PMID: 22280073 Free PMC article.

5

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. C Kitchener H, et al. Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230. Health Technol Assess. 2014. PMID: 24762804 Free PMC article. Clinical Trial.

6

Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.

Kudoh A, Sato S, Itamochi H, Komatsu H, Nonaka M, Sato S, Chikumi J, Shimada M, Oishi T, Kigawa J, Harada T. Kudoh A, et al. Int J Clin Oncol. 2016 Jun;21(3):580-7. doi: 10.1007/s10147-015-0929-x. Epub 2015 Nov 27. Int J Clin Oncol. 2016. PMID: 26614089

7

Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear.

Berkhof J, Bulkmans NW, Bleeker MC, Bulk S, Snijders PJ, Voorhorst FJ, Meijer CJ. Berkhof J, et al. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1268-73. doi: 10.1158/1055-9965.EPI-05-0764. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835322 Free article.

8

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.

Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ. Rijkaart DC, et al. Lancet Oncol. 2012 Jan;13(1):78-88. doi: 10.1016/S1470-2045(11)70296-0. Epub 2011 Dec 14. Lancet Oncol. 2012. PMID: 22177579 Clinical Trial.

9

Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.

Zhou H, Mody RR, Luna E, Armylagos D, Xu J, Schwartz MR, Mody DR, Ge Y. Zhou H, et al. Cancer Cytopathol. 2016 May;124(5):317-23. doi: 10.1002/cncy.21687. Epub 2016 Jan 15. Cancer Cytopathol. 2016. PMID: 26774025 Free article.

10

The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.

Safaeian M, Wright TC Jr, Stoler MH, Ranger-Moore J, Rehm S, Aslam S, Fang Q, Volkir P, Ridder R. Safaeian M, et al. Am J Obstet Gynecol. 2021 Sep;225(3):278.e1-278.e16. doi: 10.1016/j.ajog.2021.03.047. Epub 2021 Apr 20. Am J Obstet Gynecol. 2021. PMID: 33852886 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

120 results

Results by year